Declan M. McLoughlin - Publications

Psychiatry Trinity College, Dublin, Dublin, County Dublin, Ireland 
Alzheimer¡¯s disease, Depression, Schizophrenia

100 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Allen AP, Naughton M, Dowling J, Walsh A, Ismail F, Shorten G, Scott L, McLoughlin DM, Cryan JF, Dinan TG, Clarke G. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT. Journal of Affective Disorders. 186: 306-311. PMID 26275358 DOI: 10.1016/j.jad.2015.06.033  1
2015 Jelovac A, OʼConnor S, McCarron S, McLoughlin DM. Autobiographical Memory Specificity in Major Depression Treated With Electroconvulsive Therapy. The Journal of Ect. PMID 26252557 DOI: 10.1097/YCT.0000000000000267  1
2015 Semkovska M, Lambe S, Lonargáin DÓ, McLoughlin DM. Neurocognitive Remediation Therapy for Depression: A Feasibility Study and Randomized Controlled Pilot Protocol Testing. The Journal of Nervous and Mental Disease. 203: 609-16. PMID 26153888 DOI: 10.1097/NMD.0000000000000337  1
2015 Hester L, O'Doherty LJ, Schnittger R, Skelly N, O'Donnell M, Butterly L, Browne R, Frorath C, Morgan C, McLoughlin DM, Fearon P. SEQUenCE: a service user-centred quality of care instrument for mental health services. International Journal For Quality in Health Care : Journal of the International Society For Quality in Health Care / Isqua. 27: 284-90. PMID 26082461 DOI: 10.1093/intqhc/mzv043  1
2014 O'Donovan SM, O'Mara S, Dunn MJ, McLoughlin DM. The persisting effects of electroconvulsive stimulation on the hippocampal proteome. Brain Research. 1593: 106-16. PMID 25451099 DOI: 10.1016/j.brainres.2014.10.020  1
2014 Glaviano A, O'Donovan SM, Ryan K, O'Mara S, Dunn MJ, McLoughlin DM. Acute phase plasma proteins are altered by electroconvulsive stimulation. Journal of Psychopharmacology (Oxford, England). 28: 1125-34. PMID 25271216 DOI: 10.1177/0269881114552742  1
2014 Semkovska M, McLoughlin DM. Retrograde autobiographical amnesia after electroconvulsive therapy: on the difficulty of finding the baby and clearing murky bathwater. The Journal of Ect. 30: 187-8; discussion 18. PMID 24755723 DOI: 10.1097/YCT.0000000000000122  1
2014 Noone M, Semkovska M, Carton M, Dunne R, Horgan JP, O'Kane B, McLoughlin DM. Construction and updating of a public events questionnaire for repeated measures longitudinal studies. Frontiers in Psychology. 5: 230. PMID 24678306 DOI: 10.3389/fpsyg.2014.00230  1
2014 Lambe S, Mogg A, Eranti S, Pluck G, Hastilow S, McLoughlin DM. Trends in use of electroconvulsive therapy in South London from 1949 to 2006. The Journal of Ect. 30: 309-14. PMID 24625707 DOI: 10.1097/YCT.0000000000000112  1
2014 O'Donovan S, Dalton V, Harkin A, McLoughlin DM. Effects of brief pulse and ultrabrief pulse electroconvulsive stimulation on rodent brain and behaviour in the corticosterone model of depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1477-86. PMID 24607259 DOI: 10.1017/S1461145714000200  1
2014 Smith KJ, Mullally S, McLoughlin D, O'Mara S. Validation of the face-name pairs task in major depression: impaired recall but not recognition. Frontiers in Psychology. 5: 92. PMID 24575068 DOI: 10.3389/fpsyg.2014.00092  1
2014 Dalton VS, Kolshus E, McLoughlin DM. Epigenetics and depression: return of the repressed. Journal of Affective Disorders. 155: 1-12. PMID 24238955 DOI: 10.1016/j.jad.2013.10.028  1
2014 Kolshus E, Dalton VS, Ryan KM, McLoughlin DM. When less is more--microRNAs and psychiatric disorders. Acta Psychiatrica Scandinavica. 129: 241-56. PMID 23952691 DOI: 10.1111/acps.12191  1
2013 Skelly N, Schnittger RI, Butterly L, Frorath C, Morgan C, McLoughlin DM, Fearon P. Quality of care in psychosis and bipolar disorder from the service user perspective. Qualitative Health Research. 23: 1672-85. PMID 24163347 DOI: 10.1177/1049732313509896  1
2013 Thekiso TB, Heron EA, Masood B, Murphy M, McLoughlin DM, Kennedy N. Mauling of the "Celtic Tiger": clinical characteristics and outcome of first-episode depression secondary to the economic recession in Ireland. Journal of Affective Disorders. 151: 455-60. PMID 23948630 DOI: 10.1016/j.jad.2013.06.024  1
2013 Agyapong VI, McLoughlin DM, Farren CK. Six-months outcomes of a randomised trial of supportive text messaging for depression and comorbid alcohol use disorder. Journal of Affective Disorders. 151: 100-4. PMID 23800443 DOI: 10.1016/j.jad.2013.05.058  1
2013 Jelovac A, Kolshus E, McLoughlin DM. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2467-74. PMID 23774532 DOI: 10.1038/npp.2013.149  1
2013 Ryan KM, O'Donovan SM, McLoughlin DM. Electroconvulsive stimulation alters levels of BDNF-associated microRNAs. Neuroscience Letters. 549: 125-9. PMID 23721784 DOI: 10.1016/j.neulet.2013.05.035  1
2013 Agyapong VI, Milnes J, McLoughlin DM, Farren CK. Perception of patients with alcohol use disorder and comorbid depression about the usefulness of supportive text messages. Technology and Health Care : Official Journal of the European Society For Engineering and Medicine. 21: 31-9. PMID 23358057 DOI: 10.3233/THC-120707  1
2013 Semkovska M, McLoughlin DM. Measuring retrograde autobiographical amnesia following electroconvulsive therapy: historical perspective and current issues. The Journal of Ect. 29: 127-33. PMID 23303426 DOI: 10.1097/YCT.0b013e318279c2c9  1
2012 Frodl T, Carballedo A, Hughes MM, Saleh K, Fagan A, Skokauskas N, McLoughlin DM, Meaney J, O'Keane V, Connor TJ. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Translational Psychiatry. 2: e88. PMID 22832853 DOI: 10.1038/tp.2012.14  1
2012 Hughes MM, Carballedo A, McLoughlin DM, Amico F, Harkin A, Frodl T, Connor TJ. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Brain, Behavior, and Immunity. 26: 979-87. PMID 22683764 DOI: 10.1016/j.bbi.2012.05.010  1
2012 Agyapong VI, Ahern S, McLoughlin DM, Farren CK. Supportive text messaging for depression and comorbid alcohol use disorder: single-blind randomised trial. Journal of Affective Disorders. 141: 168-76. PMID 22464008 DOI: 10.1016/j.jad.2012.02.040  1
2012 Semkovska M, Noone M, Carton M, McLoughlin DM. Measuring consistency of autobiographical memory recall in depression. Psychiatry Research. 197: 41-8. PMID 22397910 DOI: 10.1016/j.psychres.2011.12.010  1
2012 O'Donovan S, Kennedy M, Guinan B, O'Mara S, McLoughlin DM. A comparison of brief pulse and ultrabrief pulse electroconvulsive stimulation on rodent brain and behaviour. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 37: 147-52. PMID 22230649 DOI: 10.1016/j.pnpbp.2011.12.012  1
2012 Hao Y, Chai KH, McLoughlin DM, Chan HY, Lau KF. Promoter characterization and genomic organization of the human X11β gene APBA2. Neuroreport. 23: 146-51. PMID 22222501 DOI: 10.1097/WNR.0b013e32834f1934  1
2012 Chai KH, McLoughlin DM, Chan TF, Chan HY, Lau KF. Genomic organization and promoter cloning of the human X11α gene APBA1. Dna and Cell Biology. 31: 651-9. PMID 22136355 DOI: 10.1089/dna.2011.1447  1
2012 Dunne RA, McLoughlin DM. Systematic review and meta-analysis of bifrontal electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in depression. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 13: 248-58. PMID 22098115 DOI: 10.3109/15622975.2011.615863  1
2012 Manser C, Guillot F, Vagnoni A, Davies J, Lau KF, McLoughlin DM, De Vos KJ, Miller CC. Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo. Oncogene. 31: 2773-82. PMID 21996745 DOI: 10.1038/onc.2011.437  1
2012 Agyapong VIO, McLoughlin D. Promoting psychiatry as a career option for Ghanaian medical students through a public-speaking competition Academic Psychiatry. 36: 229-232. DOI: 10.1176/appi.ap.11010016  1
2012 Dunne RA, McLoughlin DM. Physical treatments Medicine (United Kingdom). 40: 672-673. DOI: 10.1016/j.mpmed.2012.09.004  1
2011 Eranti SV, Thirthalli J, Pattan V, Mogg A, Pluck G, Velayudhan L, Chan J, Gangadhar BN, McLoughlin DM. Comparison of electroconvulsive therapy practice between London and Bengaluru. The Journal of Ect. 27: 275-80. PMID 21673590 DOI: 10.1097/YCT.0b013e31820f8f7c  1
2011 Dunne R, McLoughlin DM. Regional variation in electroconvulsive therapy use. Irish Medical Journal. 104: 84-7. PMID 21667613  1
2011 Wassif WS, McLoughlin DM, Vincent RP, Conroy S, Russell GF, Taylor NF. Steroid metabolism and excretion in severe anorexia nervosa: effects of refeeding. The American Journal of Clinical Nutrition. 93: 911-7. PMID 21367953 DOI: 10.3945/ajcn.111.012666  1
2011 Semkovska M, Keane D, Babalola O, McLoughlin DM. Unilateral brief-pulse electroconvulsive therapy and cognition: effects of electrode placement, stimulus dosage and time. Journal of Psychiatric Research. 45: 770-80. PMID 21109254 DOI: 10.1016/j.jpsychires.2010.11.001  1
2011 Agyapong VIO, Farren CK, McLoughlin DM. Mobile Phone Text Message Interventions in Psychiatry - what are the possibilities? Current Psychiatry Reviews. 7: 50-56. DOI: 10.2174/157340011795945847  1
2010 Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biological Psychiatry. 68: 568-77. PMID 20673880 DOI: 10.1016/j.biopsych.2010.06.009  1
2010 Lau KF, Perkinton MS, Rodriguez L, McLoughlin DM, Miller CC. An X11alpha/FSBP complex represses transcription of the GSK3beta gene promoter. Neuroreport. 21: 761-6. PMID 20531236 DOI: 10.1097/WNR.0b013e32833bfca0  1
2010 Mitchell JC, Perkinton MS, Yates DM, Lau KF, Rogelj B, Miller CC, McLoughlin DM. Expression of the neuronal adaptor protein X11alpha protects against memory dysfunction in a transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 20: 31-6. PMID 20378958 DOI: 10.3233/JAD-2009-1341  1
2010 Tudor EL, Galtrey CM, Perkinton MS, Lau KF, De Vos KJ, Mitchell JC, Ackerley S, Hortobágyi T, Vámos E, Leigh PN, Klasen C, McLoughlin DM, Shaw CE, Miller CC. Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience. 167: 774-85. PMID 20188146 DOI: 10.1016/j.neuroscience.2010.02.035  1
2010 Yu HT, Chan WW, Chai KH, Lee CW, Chang RC, Yu MS, McLoughlin DM, Miller CC, Lau KF. Transcriptional regulation of human FE65, a ligand of Alzheimer's disease amyloid precursor protein, by Sp1. Journal of Cellular Biochemistry. 109: 782-93. PMID 20091743 DOI: 10.1002/jcb.22457  1
2010 Tracy DK, O'Daly O, Joyce DW, Michalopoulou PG, Basit BB, Dhillon G, McLoughlin DM, Shergill SS. An evoked auditory response fMRI study of the effects of rTMS on putative AVH pathways in healthy volunteers. Neuropsychologia. 48: 270-7. PMID 19769994 DOI: 10.1016/j.neuropsychologia.2009.09.013  1
2009 Kavanagh A, McLoughlin DM. Electroconvulsive therapy and nursing care. British Journal of Nursing (Mark Allen Publishing). 18: 1370, 1372, 1374-7. PMID 20081692 DOI: 10.12968/bjon.2009.18.22.45564  1
2009 Mitchell JC, Ariff BB, Yates DM, Lau KF, Perkinton MS, Rogelj B, Stephenson JD, Miller CC, McLoughlin DM. X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice. Human Molecular Genetics. 18: 4492-500. PMID 19744962 DOI: 10.1093/hmg/ddp408  1
2009 Stevenson A, Yates DM, Manser C, De Vos KJ, Vagnoni A, Leigh PN, McLoughlin DM, Miller CC. Riluzole protects against glutamate-induced slowing of neurofilament axonal transport. Neuroscience Letters. 454: 161-4. PMID 19429076 DOI: 10.1016/j.neulet.2009.02.061  1
2009 Yates DM, Manser C, De Vos KJ, Shaw CE, McLoughlin DM, Miller CC. Neurofilament subunit (NFL) head domain phosphorylation regulates axonal transport of neurofilaments. European Journal of Cell Biology. 88: 193-202. PMID 19147253 DOI: 10.1016/j.ejcb.2008.11.004  1
2009 Eranti SV, Mogg AJ, Pluck GC, Landau S, McLoughlin DM. Methohexitone, propofol and etomidate in electroconvulsive therapy for depression: a naturalistic comparison study. Journal of Affective Disorders. 113: 165-71. PMID 18439686 DOI: 10.1016/j.jad.2008.03.004  1
2009 Kelly BD, McLoughlin DM. Physician-assisted suicide and psychiatry Psychiatry. 8: 276-279. DOI: 10.1016/j.mppsy.2009.04.011  1
2009 Dunne R, Kavanagh A, McLoughlin DM. Electroconvulsive therapy, capacity and the law in Ireland Irish Journal of Psychological Medicine. 26: 3-5.  1
2008 Lau KF, Chan WM, Perkinton MS, Tudor EL, Chang RC, Chan HY, McLoughlin DM, Miller CC. Dexras1 interacts with FE65 to regulate FE65-amyloid precursor protein-dependent transcription. The Journal of Biological Chemistry. 283: 34728-37. PMID 18922798 DOI: 10.1074/jbc.M801874200  1
2008 Manser C, Stevenson A, Banner S, Davies J, Tudor EL, Ono Y, Leigh PN, McLoughlin DM, Shaw CE, Miller CC. Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport. Febs Letters. 582: 2303-8. PMID 18519042 DOI: 10.1016/j.febslet.2008.05.034  1
2008 McLoughlin DM. Vagus rules still apply. Psychological Medicine. 38: 625-7. PMID 18494108 DOI: 10.1017/S0033291707002565  1
2008 O'Riordan JM, Healy CF, McLoughlin D, Cassidy M, Brannigan AE, O'Connell PR. Sacral nerve stimulation for faecal incontinence Irish Journal of Medical Science. 177: 117-119. PMID 18392782 DOI: 10.1007/s11845-008-0145-z  1
2008 Knapp M, Romeo R, Mogg A, Eranti S, Pluck G, Purvis R, Brown RG, Howard R, Philpot M, Rothwell J, Edwards D, McLoughlin DM. Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: a multi-centre randomised controlled trial. Journal of Affective Disorders. 109: 273-85. PMID 18262655 DOI: 10.1016/j.jad.2008.01.001  1
2008 Mogg A, Pluck G, Eranti SV, Landau S, Purvis R, Brown RG, Curtis V, Howard R, Philpot M, McLoughlin DM. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression. Psychological Medicine. 38: 323-33. PMID 17935639 DOI: 10.1017/S0033291707001663  1
2008 McLoughlin DM, Miller CC. The FE65 proteins and Alzheimer's disease. Journal of Neuroscience Research. 86: 744-54. PMID 17828772 DOI: 10.1002/jnr.21532  1
2008 Hotopf M, Laird B, Singh I, Churchill R, David AS, McLoughlin DM, Richardson G, Szmukler G. Capacity, consent and electroconvulsive therapy: A qualitative and cross-sectional study Journal of Mental Health. 17: 315-325. DOI: 10.1080/09638230701879128  1
2008 Yates D, McLoughlin DM. The molecular pathology of Alzheimer's disease Psychiatry. 7: 1-5. DOI: 10.1016/j.mppsy.2007.11.009  1
2007 De Vos KJ, Chapman AL, Tennant ME, Manser C, Tudor EL, Lau KF, Brownlees J, Ackerley S, Shaw PJ, McLoughlin DM, Shaw CE, Leigh PN, Miller CC, Grierson AJ. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Human Molecular Genetics. 16: 2720-8. PMID 17725983 DOI: 10.1093/hmg/ddm226  1
2007 McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, Landau S, Brown R, Rabe-Heskith S, Howard R, Philpot M, Rothwell J, Romeo R, Knapp M. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis. Health Technology Assessment (Winchester, England). 11: 1-54. PMID 17580003  1
2007 Mogg A, Purvis R, Eranti S, Contell F, Taylor JP, Nicholson T, Brown RG, McLoughlin DM. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study. Schizophrenia Research. 93: 221-8. PMID 17478080 DOI: 10.1016/j.schres.2007.03.016  1
2007 Eranti S, Mogg A, Pluck G, Landau S, Purvis R, Brown RG, Howard R, Knapp M, Philpot M, Rabe-Hesketh S, Romeo R, Rothwell J, Edwards D, McLoughlin DM. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. The American Journal of Psychiatry. 164: 73-81. PMID 17202547 DOI: 10.1176/appi.ajp.164.1.73  1
2007 McLoughlin DM. Dr. McLoughlin replies [2] American Journal of Psychiatry. 164: 1118-1119.  1
2006 Rogelj B, Mitchell JC, Miller CC, McLoughlin DM. The X11/Mint family of adaptor proteins. Brain Research Reviews. 52: 305-15. PMID 16764936 DOI: 10.1016/j.brainresrev.2006.04.005  1
2006 Miller CC, McLoughlin DM, Lau KF, Tennant ME, Rogelj B. The X11 proteins, Abeta production and Alzheimer's disease. Trends in Neurosciences. 29: 280-5. PMID 16545469 DOI: 10.1016/j.tins.2006.03.001  1
2005 Mineur YS, McLoughlin D, Crusio WE, Sluyter F. Genetic mouse models of Alzheimer's disease. Neural Plasticity. 12: 299-310. PMID 16444901 DOI: 10.1155/NP.2005.299  1
2005 Uher R, Yoganathan D, Mogg A, Eranti SV, Treasure J, Campbell IC, McLoughlin DM, Schmidt U. Effect of left prefrontal repetitive transcranial magnetic stimulation on food craving. Biological Psychiatry. 58: 840-2. PMID 16084855 DOI: 10.1016/j.biopsych.2005.05.043  1
2005 Tudor EL, Perkinton MS, Schmidt A, Ackerley S, Brownlees J, Jacobsen NJ, Byers HL, Ward M, Hall A, Leigh PN, Shaw CE, McLoughlin DM, Miller CC. ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth. The Journal of Biological Chemistry. 280: 34735-40. PMID 16049005 DOI: 10.1074/jbc.M506216200  1
2004 Lee JH, Lau KF, Perkinton MS, Standen CL, Rogelj B, Falinska A, McLoughlin DM, Miller CC. The neuronal adaptor protein X11beta reduces amyloid beta-protein levels and amyloid plaque formation in the brains of transgenic mice. The Journal of Biological Chemistry. 279: 49099-104. PMID 15347685 DOI: 10.1074/jbc.M405602200  1
2004 Perkinton MS, Standen CL, Lau KF, Kesavapany S, Byers HL, Ward M, McLoughlin DM, Miller CC. The c-Abl tyrosine kinase phosphorylates the Fe65 adaptor protein to stimulate Fe65/amyloid precursor protein nuclear signaling. The Journal of Biological Chemistry. 279: 22084-91. PMID 15031292 DOI: 10.1074/jbc.M311479200  1
2003 Standen CL, Perkinton MS, Byers HL, Kesavapany S, Lau KF, Ward M, McLoughlin D, Miller CC. The neuronal adaptor protein Fe65 is phosphorylated by mitogen-activated protein kinase (ERK1/2). Molecular and Cellular Neurosciences. 24: 851-7. PMID 14697653 DOI: 10.1016/j.mcn.2003.07.002  1
2003 Lee JH, Lau KF, Perkinton MS, Standen CL, Shemilt SJ, Mercken L, Cooper JD, McLoughlin DM, Miller CC. The neuronal adaptor protein X11alpha reduces Abeta levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice. The Journal of Biological Chemistry. 278: 47025-9. PMID 12970358 DOI: 10.1074/jbc.M300503200  1
2003 Kemsley S, Eranti SV, McLoughlin DM. Changing use of ECT [6] (multiple letters) British Journal of Psychiatry. 183: 172-173. PMID 12893677 DOI: 10.1192/bjp.183.2.172  1
2003 Kesavapany S, Lau KF, Ackerley S, Banner SJ, Shemilt SJ, Cooper JD, Leigh PN, Shaw CE, McLoughlin DM, Miller CC. Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinase. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4975-83. PMID 12832520  1
2003 Eranti SV, McLoughlin DM. Electroconvulsive therapy - state of the art. The British Journal of Psychiatry : the Journal of Mental Science. 182: 8-9. PMID 12509311 DOI: 10.1192/bjp.182.1.8  1
2003 McLoughlin DM. Review: Repetitive transcranial magnetic stimulation is of unknown effectiveness in people with depression: Commentary Evidence-Based Mental Health. 6: 118. DOI: 10.1136/ebmh.6.4.118  1
2002 Kesavapany S, Banner SJ, Lau KF, Shaw CE, Miller CC, Cooper JD, McLoughlin DM. Expression of the Fe65 adapter protein in adult and developing mouse brain. Neuroscience. 115: 951-60. PMID 12435432 DOI: 10.1016/S0306-4522(02)00422-0  1
2002 Kelly BD, McLoughlin DM. Euthanasia, assisted suicide and psychiatry: a Pandora's box. The British Journal of Psychiatry : the Journal of Mental Science. 181: 278-9. PMID 12356652 DOI: 10.1192/bjp.181.4.278  1
2002 Lau KF, Howlett DR, Kesavapany S, Standen CL, Dingwall C, McLoughlin DM, Miller CC. Cyclin-dependent kinase-5/p35 phosphorylates Presenilin 1 to regulate carboxy-terminal fragment stability. Molecular and Cellular Neurosciences. 20: 13-20. PMID 12056836 DOI: 10.1006/mcne.2002.1108  1
2002 Lovestone S, McLoughlin DM. Protein aggregates and dementia: is there a common toxicity? Journal of Neurology, Neurosurgery, and Psychiatry. 72: 152-61. PMID 11796764 DOI: 10.1136/jnnp.72.2.152  1
2001 Lyons D, McLoughlin DM. Recent advances: Psychiatry. Bmj (Clinical Research Ed.). 323: 1228-31. PMID 11719415  1
2001 Kesavapany S, Lau KF, McLoughlin DM, Brownlees J, Ackerley S, Leigh PN, Shaw CE, Miller CC. p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction. The European Journal of Neuroscience. 13: 241-7. PMID 11168528 DOI: 10.1046/j.1460-9568.2001.01376.x  1
2001 Standen CL, Brownlees J, Grierson AJ, Kesavapany S, Lau KF, McLoughlin DM, Miller CC. Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3). Journal of Neurochemistry. 76: 316-20. PMID 11146006 DOI: 10.1046/j.1471-4159.2001.00102.x  1
2001 McLoughlin DM, Standen CL, Lau KF, Ackerley S, Bartnikas TP, Gitlin JD, Miller CC. The neuronal adaptor protein X11alpha interacts with the copper chaperone for SOD1 and regulates SOD1 activity. The Journal of Biological Chemistry. 276: 9303-7. PMID 11115513 DOI: 10.1074/jbc.M010023200  1
2000 Lau KF, McLoughlin DM, Standen CL, Irving NG, Miller CC. Fe65 and X11beta co-localize with and compete for binding to the amyloid precursor protein. Neuroreport. 11: 3607-10. PMID 11095528  1
2000 Lau KF, McLoughlin DM, Standen C, Miller CC. X11 alpha and x11 beta interact with presenilin-1 via their PDZ domains. Molecular and Cellular Neurosciences. 16: 557-65. PMID 11083918 DOI: 10.1006/mcne.2000.0898  1
2000 McLoughlin DM, Wassif WS, Morton J, Spargo E, Peters TJ, Russell GF. Metabolic abnormalities associated with skeletal myopathy in severe anorexia nervosa. Nutrition (Burbank, Los Angeles County, Calif.). 16: 192-6. PMID 10705074 DOI: 10.1016/S0899-9007(99)00286-5  1
2000 McLoughlin D. Transition, transformation and the art of losing: Some uses of poetry in hospice care for the terminally ill Psychodynamic Counselling. 6: 215-234.  1
1999 Morton J, McLoughlin DM, Whiting S, Russell GF. Carnitine levels in patients with skeletal myopathy due to anorexia nervosa before and after refeeding. The International Journal of Eating Disorders. 26: 341-4. PMID 10441250 DOI: 10.1002/(SICI)1098-108X(199911)26:3<341::AID-EAT12>3.0.CO;2-9  1
1999 McLoughlin DM, Irving NG, Brownlees J, Brion JP, Leroy K, Miller CC. Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease. The European Journal of Neuroscience. 11: 1988-94. PMID 10336668 DOI: 10.1046/j.1460-9568.1999.00610.x  1
1998 McLoughlin DM, Irving NG, Miller CC. The Fe65 and X11 families of proteins: proteins that interact with the Alzheimer's disease amyloid precursor protein. Biochemical Society Transactions. 26: 497-500. PMID 9765903  1
1998 McLoughlin DM, Spargo E, Wassif WS, Newham DJ, Peters TJ, Lantos PL, Russell GF. Structural and functional changes in skeletal muscle in anorexia nervosa. Acta Neuropathologica. 95: 632-40. PMID 9650756 DOI: 10.1007/s004010050850  1
1998 Blanco G, Irving NG, Brown SD, Miller CC, McLoughlin DM. Mapping of the human and murine X11-like genes (APBA2 and apba2), the murine Fe65 gene (Apbb1), and the human Fe65-like gene (APBB2): genes encoding phosphotyrosine-binding domain proteins that interact with the Alzheimer's disease amyloid precursor protein. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 9: 473-5. PMID 9585438 DOI: 10.1007/s003359900800  1
1998 Guidato S, McLoughlin DM, Grierson AJ, Miller CC. Cyclin D2 interacts with cdk-5 and modulates cellular cdk-5/p35 activity. Journal of Neurochemistry. 70: 335-40. PMID 9422379  1
1996 Holmes C, Levy R, McLoughlin DM, Powell JF, Lovestone S. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 61: 580-3. PMID 8971103  1
1996 McLoughlin DM, Miller CC. The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine-binding domain proteins in the yeast two-hybrid system. Febs Letters. 397: 197-200. PMID 8955346 DOI: 10.1016/S0014-5793(96)01128-3  1
1996 McLoughlin DM, Cooney C, Holmes C, Levy R. Carer informants for dementia sufferers: carer awareness of cognitive impairment in an elderly community-resident sample. Age and Ageing. 25: 367-71. PMID 8921141 DOI: 10.1093/ageing/25.5.367  1
1996 McLoughlin DM, Levy R. The differential diagnosis of dementia. Acta Neurologica Scandinavica. Supplementum. 165: 92-100. PMID 8740994 DOI: 10.1111/j.1600-0404.1996.tb05877.x  1
1994 McLoughlin DM, Lucey JV, Dinan TG. Central serotonergic hyperresponsivity in late-onset Alzheimer's disease. The American Journal of Psychiatry. 151: 1701-3. PMID 7943465  1
1994 McLoughlin DM, Lovestone S. Alzheimer's disease: Recent advances in molecular pathology and genetics International Journal of Geriatric Psychiatry. 9: 431-444. DOI: 10.1002/gps.930090602  1
Show low-probability matches.